ChemicalBook > CAS DataBase List > Trastuzumab emtansine

Trastuzumab emtansine

Product Name
Trastuzumab emtansine
CAS No.
1018448-65-1
Chemical Name
Trastuzumab emtansine
Synonyms
T-DM1;Kadcyla;PRO132365;trastuzumab-DM1;trastuzumab-MCC-DM1;trastuzumab emtansine;Ado-trastuzumab emtansine;Ado-trastuzuMab-eMtansine cas nr;Ado-trastuzumab Emtansine (TDM-1);trastuzumab-MCC-DM1 antibody-drug conjugate
CBNumber
CB12672561
Formula Weight
0
MOL File
Mol file
More
Less

Trastuzumab emtansine Property

storage temp. 
Store at -20°C
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Danger
Hazard statements

H300Fatal if swallowed

H315Causes skin irritation

H330Fatal if inhaled

H340May cause genetic defects

H351Suspected of causing cancer

H360May damage fertility or the unborn child

H371May cause damage to organs

Precautionary statements

P201Obtain special instructions before use.

P202Do not handle until all safety precautions have been read and understood.

P260Do not breathe dust/fume/gas/mist/vapours/spray.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P271Use only outdoors or in a well-ventilated area.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P281Use personal protective equipment as required.

P284Wear respiratory protection.

P301+P310IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P304+P340IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.

P308+P313IF exposed or concerned: Get medical advice/attention.

P309+P311IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.

P310Immediately call a POISON CENTER or doctor/physician.

P320Specific treatment is urgent (see … on this label).

P321Specific treatment (see … on this label).

P330Rinse mouth.

P332+P313IF SKIN irritation occurs: Get medical advice/attention.

P362Take off contaminated clothing and wash before reuse.

P403+P233Store in a well-ventilated place. Keep container tightly closed.

P405Store locked up.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

ChemScene
Product number
CS-0031062
Product name
Trastuzumabemtansine
Packaging
5mg
Price
$1600
Updated
2021/12/16
ChemScene
Product number
CS-0031062
Product name
Trastuzumabemtansine
Packaging
10mg
Price
$2600
Updated
2021/12/16
More
Less

Trastuzumab emtansine Chemical Properties,Usage,Production

Description

T-DM1 is a human epidermal growth factor receptor (HER2)-targeted antibody drug conjugate (ADC) that was approved in February 2013 by the US FDA for use as a single agent for the treatment of patients with HER2-positive, metastatic breast cancer (mBC) who previously received treatment with trastuzumab and a taxane, separately, or in combination. T-DM1 is composed of trastuzumab linked to the potent cytotoxic microtubule polymerization inhibitor DM1 (derivative of maytansine) via a stable uncleavable thioether linker. T-DM1 is produced by chemically crosslinking the cytotoxic maytansinoid derivative to the lysine residues of trastuzumab such that there is an average of 3.5 cytotoxic molecules linked to each antibody. In addition to delivering DM1 to tumor cells, T-DM1 retains the effector functions of trastuzumab, including inhibition of HER2-mediated signal transduction and activation of antibodydependent cell-mediated cytotoxicity.

Originator

Genentech, a member of the Roche Group (United States)

brand name

Kadcyla

Synthesis

First, commercial 3-mercaptopropionic acid (191) was treated with methanethiolsufonate to give the corresponding methyldithio analog 192 in 90% yield. Activation of the acid with N-hydroxysuccinimide in the presence of 1-ethyl-3-(3-dimethylaminopropyl)- carbodiimide (EDCI) provided the activated ester 193, which was reacted with N-methyl-L-alanine (194) to give acid 195 in 60% yield from compound 192.

Preparation of the DM1 linker-payload is described in above. The starting material used for the production of DM1 is ansamitocin P-3 (196), which is produced via fermentation of the microorganism Actinosynnema pretiosum. The ester group of 196 was removed using a reductive process in the presence of lithium trimethoxyaluminum hydride to give maytansinol 197 in 85% yield. The use of reductive conditions was required to avoid subsequent elimination to the a,b-unsaturated amide. Esterification with 195 in the presence of 1,3-dicyclohexylcarbodiimide (DCC) and zinc chloride provided DM1¨CSMe 198 in 32% yield. Reductive removal of the dithiane using dithiothreitol (DTT) in aqueous buffer at pH 7.5 gave DM1 thiol 199 in 76% yield, which was utilized in the conjugation to trastuzumab (200).

Completion of the synthesis of trastuzumab emtansine is described in above. The surface accessible lysine residues of trastuzumab (200) were treated with succinimidyl-4-(N-maleimidomethyl)- cyclohexane-carboxylate (SMCC, 201) in pH 7.0 buffer to give amide 202 with approximately four SMCC molecules added per antibody in 88% yield. Next, the free thiol group of DM1 (199) was conjugated to the maleimide groups present on 202 to give trastuzumab emtansine (XXV) with an average 3.5 drug molecules loaded per antibody.

Trastuzumab emtansine Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Trastuzumab emtansine Suppliers

Shanghai jerryxing Biomedical Technology Co., Ltd
Tel
17721492509
Email
643638326@qq.com
Country
China
ProdList
5347
Advantage
58
Chembest Research Laboratories Limited
Tel
021-20908456
Fax
021-58180499
Email
sales@BioChemBest.com
Country
China
ProdList
6010
Advantage
61
Wuhan Sunrise Technology Development Co., Ltd.
Tel
027-027-83314682 13554138826
Fax
+86 (27) 8331-4682
Email
whsrtech@vip.163.com
Country
China
ProdList
300
Advantage
62
EnliPharma Technology Co., Ltd
Tel
0551-66399836 18955197623
Email
sales@enlipharma.com
Country
China
ProdList
1874
Advantage
55
Nanjing Vital Chemical Co., Ltd.
Tel
025-87193546 18652950785
Fax
025-87193546
Email
chemweiao@163.com
Country
China
ProdList
9030
Advantage
60
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9709
Advantage
58
ShangHai Biochempartner Co.,Ltd
Tel
17754423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8011
Advantage
62
Career Henan Chemica Co
Tel
+86-0371-86658258 15093356674;
Fax
0371-86658258
Email
laboratory@coreychem.com
Country
China
ProdList
30255
Advantage
58
Guangzhou Hongyuan Chemical Co.,Ltd
Tel
15817493340
Email
981810490@qq.com
Country
China
ProdList
478
Advantage
58
Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Fax
QQ:422450190
Email
422450190@qq.com
Country
China
ProdList
10055
Advantage
58
Shanghai Minkai Biological Technology Co., Ltd
Tel
021-52919136 17315815539
Email
2804155403@qq.com
Country
China
ProdList
169
Advantage
58
Wuhan Topule
Tel
+86-02787215551 +86-19945035818
Fax
027-87215551
Email
2936752263@qq.com
Country
China
ProdList
8287
Advantage
58
Beijing Jin Ming Biotechnology Co., Ltd.
Tel
010-60605840
Email
psaitong@jm-bio.com
Country
China
ProdList
29778
Advantage
58
Jiangxi ravel Biotechnology Co.,Ltd
Tel
13184580281
Fax
400-880-2824
Email
hj@ruiweier.cn
Country
China
ProdList
2105
Advantage
58
Hubei Kele Fine Chemical Co., Ltd
Tel
027-59101668 19945030958
Fax
027-59101668
Email
2881924765@qq.com
Country
China
ProdList
7973
Advantage
58
Hubei wei shi reagent group ltd., company
Tel
186-27096350 18627096350
Fax
027-59379337
Email
2853877630@qq.com
Country
China
ProdList
2638
Advantage
58
Wuhan Augda Biotechnology Co., Ltd
Tel
15071299552
Fax
QQ:262933239
Email
262933239@qq.com
Country
China
ProdList
6637
Advantage
58
Wuhan Yingnuo Pharmaceutical Technology Co., Ltd.
Tel
+86-027-59232304 15387063101
Email
2881924050@qq.com
Country
China
ProdList
9892
Advantage
58
Xianning Shen Lan Biomedical Research and Development Co., Ltd.
Tel
18171815831
Email
1341138380@qq.com
Country
China
ProdList
2780
Advantage
58
Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel
13720134139 13720134139
Email
orders@jknbiochem.com
Country
China
ProdList
5278
Advantage
58
Wuhan Acumen Bio-Technology Co.,ltd
Tel
027-027-16602739303 16602739303
Email
673003916@qq.com
Country
China
ProdList
2942
Advantage
58
Shanghai?Medlife?Pharm-Tech?Co.,?Ltd
Tel
021-59167510 18117107507
Email
vip@med-life.cn
Country
China
ProdList
5019
Advantage
58
Changsha Fuzhen Biotechnology Co.,LTD
Tel
0731-18670069958 18670069958
Email
184792226@qq.com
Country
China
ProdList
3060
Advantage
58
bioleaper
Tel
18601717983
Email
guojing@bioleaper.com
Country
China
ProdList
5615
Advantage
58
Hubei wei shi reagent group ltd., company
Tel
027-027-59102966 18717199209
Email
2853877583@qq.com
Country
China
ProdList
5884
Advantage
58
Hubei wei shi reagent group ltd., company
Tel
027-59101766 13125137661
Email
2853877621@qq.com
Country
China
ProdList
3771
Advantage
58
TargetMol Chemicals Inc.
Tel
15002134094
Email
marketing@targetmol.com
Country
China
ProdList
24246
Advantage
58
Olix (Shanghai) Pharmaceutical Technology Co., Ltd
Tel
17316404525
Email
209533805@qq.com
Country
China
ProdList
9621
Advantage
58
Henan Tianfu Chemical Co.,Ltd.
Tel
+86-0371-55170693 +86-19937530512
Fax
0371-55170693
Email
info@tianfuchem.com
Country
China
ProdList
21688
Advantage
55
Wuhan Jingkang en Biomedical Technology Co., Ltd
Tel
+8613720134139
Email
orders@jknbiochem.com
Country
China
ProdList
4664
Advantage
58
LEAPCHEM CO., LTD.
Tel
+86-852-30606658
Email
market18@leapchem.com
Country
China
ProdList
43348
Advantage
58
Wuhan Topule Biopharmaceutical Co., Ltd
Tel
+8618327326525
Email
masar@topule.com
Country
China
ProdList
8474
Advantage
58

1018448-65-1, Trastuzumab emtansineRelated Search:


  • Ado-trastuzuMab-eMtansine cas nr
  • trastuzumab emtansine
  • Ado-trastuzumab emtansine
  • Ado-trastuzumab Emtansine (TDM-1)
  • Kadcyla
  • PRO132365
  • T-DM1
  • trastuzumab-DM1
  • trastuzumab-MCC-DM1
  • trastuzumab-MCC-DM1 antibody-drug conjugate
  • 1018448-65-1